Krishnaprasad Subbarao

429 total citations
9 papers, 367 citations indexed

About

Krishnaprasad Subbarao is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Krishnaprasad Subbarao has authored 9 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Krishnaprasad Subbarao's work include Fibroblast Growth Factor Research (2 papers), Immunotherapy and Immune Responses (2 papers) and Immune cells in cancer (2 papers). Krishnaprasad Subbarao is often cited by papers focused on Fibroblast Growth Factor Research (2 papers), Immunotherapy and Immune Responses (2 papers) and Immune cells in cancer (2 papers). Krishnaprasad Subbarao collaborates with scholars based in United States, Finland and United Kingdom. Krishnaprasad Subbarao's co-authors include Bodduluri Haribabu, Steven Mathis, Venkatakrishna R. Jala, Wolfgang Zacharias, Jill Suttles, Michael T. Tseng, Hydar Ali, Li Wang, Jun Yan and Daniel J. Allendorf and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer Research.

In The Last Decade

Krishnaprasad Subbarao

9 papers receiving 361 citations

Peers

Countries citing papers authored by Krishnaprasad Subbarao

Since Specialization

Citations

This map shows the geographic impact of Krishnaprasad Subbarao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krishnaprasad Subbarao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krishnaprasad Subbarao more than expected).

Fields of papers citing papers by Krishnaprasad Subbarao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Krishnaprasad Subbarao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krishnaprasad Subbarao. The network helps show where Krishnaprasad Subbarao may publish in the future.

Co-authorship network of co-authors of Krishnaprasad Subbarao

This figure shows the co-authorship network connecting the top 25 collaborators of Krishnaprasad Subbarao. A scholar is included among the top collaborators of Krishnaprasad Subbarao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Krishnaprasad Subbarao. Krishnaprasad Subbarao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	A Rationally Designed Peptide Antagonist of the PD-1 Signaling Pathway as an Immunomodulatory Agent for Cancer Therapy 2019 ·Molecular Cancer Therapeutics ·Pottayil G. Sasikumar, Raghuveer Ramachandra, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Dodderi S. Samiulla, Krishnaprasad Subbarao, Rashmi Nair, Rajeev Shrimali, (unknown), Murali Ramachandra	55
2	Leukotriene B₄-receptor-1 mediated host response shapes gut microbiota and controls colon tumor progression 2017 ·OncoImmunology ·Venkatakrishna R. Jala, Paramahamsa Maturu, Sobha R. Bodduluri, (unknown), Steven Mathis, Krishnaprasad Subbarao, Min Wang, A. Bennett Jenson, Mary Proctor, Eric C. Rouchka, Rob Knight, Bodduluri Haribabu	21
3	Discovery of O-(3-carbamimidoylphenyl)-l-serine amides as matriptase inhibitors using a fragment-linking approach 2014 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Gerd Wohlfahrt, Subhendu Mukherjee, Chakshusmathi Ghadiyaram, (unknown), (unknown), Krishnaprasad Subbarao, (unknown), (unknown), Hosahalli S. Subramanya, Murali Ramachandra	8
4	Structure-guided discovery of 1,3,5 tri-substituted benzenes as potent and selective matriptase inhibitors exhibiting in vivo antitumor efficacy 2014 ·Bioorganic & Medicinal Chemistry ·(unknown), Subhendu Mukherjee, Chakshusmathi Ghadiyaram, Gerd Wohlfahrt, (unknown), (unknown), (unknown), Krishnaprasad Subbarao, (unknown), (unknown), (unknown), Tarja Ikonen, (unknown), Hosahalli S. Subramanya, Pekka Kallio, Murali Ramachandra	15
5	Abstract 2850: Demonstration of anti-tumor efficacy in multiple preclinical cancer models using a novel peptide inhibitor (Aurigene-012) of the PD1 signaling pathway 2012 ·Cancer Research ·Pottayil G. Sasikumar, (unknown), Rajeev Shrimali, Krishnaprasad Subbarao, Raghuveer Ramachandra, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Dodderi S. Samiulla, Murali Ramachandra	12
6	Inhibition of STAT3 driven gene expression in melanoma cells by SCV-07 2008 ·Journal of Clinical Oncology ·Vijaya Nagabhushanam, Krishnaprasad Subbarao, Mohanraj Ramachandran, Jyotsna Reddy, Cynthia Tuthill	1
7	C5a-Mediated Leukotriene B4-Amplified Neutrophil Chemotaxis Is Essential in Tumor Immunotherapy Facilitated by Anti-Tumor Monoclonal Antibody and β-Glucan 2005 ·The Journal of Immunology ·Daniel J. Allendorf, Jun Yan, Gordon D. Ross, Richard Hansen, Jarosław Baran, Krishnaprasad Subbarao, Li Wang, Bodduluri Haribabu	60
8	Leukotriene B₄Receptor (BLT-1) Modulates Neutrophil Influx into the Peritoneum but Not the Lung and Liver during Surgically Induced Bacterial Peritonitis in Mice 2004 ·Clinical and Vaccine Immunology ·Melanie J. Scott, William G. Cheadle, J. Jason Hoth, James C. Peyton, Krishnaprasad Subbarao, Wen-Hai Shao, Bodduluri Haribabu	21
9	Role of Leukotriene B₄Receptors in the Development of Atherosclerosis: Potential Mechanisms 2003 ·Arteriosclerosis Thrombosis and Vascular Biology ·Krishnaprasad Subbarao, Venkatakrishna R. Jala, Steven Mathis, Jill Suttles, Wolfgang Zacharias, (unknown), Hydar Ali, Michael T. Tseng, Bodduluri Haribabu	174

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact